Britain's competition watchdog said on Friday it would refer UnitedHealth Group's 1.24 billion pound ($1.54 billion) acquisition of healthcare technology firm EMIS for a Phase 2 investigation. The Competition and Markets Authority (CMA) said it had rejected a remedy offered by U.S.-based UnitedHealth after deeming it did not go far enough in mitigating the potential competitive impact of the combination. The proposed remedy was a divestiture of the domestic Medicines Optimisation and Population Health Management businesses of Optum UK, part of UnitedHealth.
Congress appears to be barreling toward a protracted fight over lifting it in the coming months—markets be damned.
HydrogenPro has today published its Integrated Report 2022, including ESG reporting and complete 2022 annual accounts with notes. Please find a PDF version of the Integrated Report, as well as the report in European Single Electronic Format (ESEF), as attachments to this release. The report is also available at the company's website.
Symbol | Last price | Change | % change |
---|---|---|---|
Symbol | Last price | Change | % change |
---|---|---|---|
Symbol | Last price | Change | % change |
---|---|---|---|
Symbol | Last price | Change | % change |
---|---|---|---|
Symbol | Last price | Change | % change |
---|---|---|---|
Symbol | Last price | Change | % change |
---|---|---|---|
Symbol | Last price | Change | % change |
---|---|---|---|